chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within a few days, I'm guessing two, of my first Shingrix vaccination, my sore back (from yard work the previous weekend) became extremely and suddenly more painful. This lasted somewhere between seven and ten days. I could not explain the sudden onset of an exacerbation of my sore lower back pain. It interfered with my normal exercise routine (speed walking or running four to six miles every day together with exercises at the park) until I recovered, approximately ten days later.   I was suspicious that it was the vaccine caused this otherwise inexplicable event, but became persuaded that it was the case when I got the second dose in the series on December 5, 2022. I was careful to schedule my shot at a time when I wasn't sore from  yard work or my exercise routine. Four days after the shot, I experienced a similar sudden onset of pain in a location of a previous injury that I thought had healed up. The location was near my left shoulder blade, which I had injured, probably from swinging on the monkey bars at the park or possibly doing my pushups. Today is the tenth day after my second Shingrix immunization. The soreness is almost gone, but I have not ventured to resume my typical exercises, since I don't want to have it return. The day that it was most painful on this second occurrence was Friday, December 9. I would characterize the pain as moderately extreme. By Saturday the intensity of this pain had subsided somewhat, but I still felt it and continue to do so.   It is as if some component of this vaccine react to areas of the body that are inflamed and produce sharp pain.
they suspect that I have rheumatoid arthritis; this is like abnormal I mean anybody with arthritis should not be a part of these trials; Never felt this kind of joint pain in my life/these are hitting my every joint in my hand, I can barely move; I have never been in as much pain in my life; I am really bad nauseous; soreness in your arm; This is a spontaneous report from a contactable consumer (patient) (Food service worker in the hospital). A 48-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: Unknown), via an unspecified route of administration on 28Dec2020 at single dose for COVID-19 immunisation.  Medical history included Meniere's disease (reported 'Meniere's disease in my left ear').  The patient's concomitant medications were not reported. Consumer stated, ''I just took the COVID 19 vaccine I work at (institute name), (city name), I took it yesterday around 1 and all through the night; they suspect that I have rheumatoid arthritis I got an injection in one of my hips, my right hip and both my shoulders I can inject in cortisone injection and I have never felt this kind of joint pain in my life, I can barely move, I had been calling and I let my director know and anybody that has any kind of arthritis on these trials, I have never been in as much pain in my life and I am really bad nauseous.'' When offered for the website consumer stated, ''I just wanted to report the side effects, I am really nauseous and I can barely move; this is like abnormal I mean anybody with arthritis should not be a part of these trials.'' When probed if vaccine was prescribed by Physician, Consumer stated, ''No it was voluntary, it was not mandatory it was given my hospital administration.'' Product details for vaccine (LOT#, Expiration date, NDC#, UPC#): Consumer stated, ''EH9894, I think for the last number.'' Treatment for adverse events: Consumer stated, ''I don't have anything for nausea, I did take, they told to me take Ibuprofen my doctor said that it would help with the soreness in your arm, I take my Ibuprofen every six hours because it is prescribed to me, but I could barely move my, I can barely move; these are hitting my every joint in my hand.'' Expiry Date of Ibuprofen: 16Jul2021. The outcome of the events was unknown.   Information on the Batch/Lot number has been requested.
Information has been received from a registered nurse concerning a 5 year old white male with no medical history or allergies who on 17-JUL-2006 was vaccinated with no medical history or allergies who on 17-JUL-2006 was vaccinated with a SC 0.5 mL second dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Suspect vaccination included a dose of diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid, a dose of poliovirus vaccine and and a dose tuberculin purified protein derivative (MANTOUX SKIN TEST). It was reported that the patient seemed to be in pain or discomfort after he was vaccinated with measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) or the diluent. The nurse administered a shot of what she thought was reconstituted measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) but shortly afterwards noticed the vial of unreconstituted measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). The nurse thought "maybe the diluent was given instead and the pain or discomfort could be related to the stinging of the diluen. Medical attention was sought. A urinary analysis was done, results not reported. The patients outcome was not reported. There was no product quality complaint involved. Follow-up information from the registered nurse indicated that "the week after 17-JUL-2006", on approximately 24-JUL-2006, the patient was vaccinated with the "proper dose" of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Within ten minutes of receiving the vaccination the child experienced a general rash with a flushing reaction. He was observed for a few hours. No treatment was required. The condition resolved. Follow-up information from the registered nurse indicated that the patient was on 21-JUL-2006 vaccinated SC in the left deltoid with the third dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (653751/0499F). There was no illness at the time of vaccination. In 21-JUl-2006, within 30 minutes of vaccination the patient returned to the office with a red rash all over and increased heart rate of 110. The patient felt weak. He was observed for several hours until resolved completely. Additional information is not expected.
Got really sick for a day about 2 weeks; Fever; Chills; Joint pains in hands, knees, hips, back and heels; Headache; Extreme fatigue; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 08Apr2021 at 11:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included attention deficit hyperactivity disorder and inflammatory arthritis. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medications included methylphenidate (MANUFACTURER UNKNOWN), multivitamins (MANUFACTURER UNKNOWN) and hydroxychloroquine (MANUFACTURER UNKNOWN) all for unknown indications from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 at 21:00 the patient got really sick (for a day), fever, chills, joint pains in hands, knees, hips, back and heels, headache, extreme fatigue and nausea. The events resulted in doctor or other healthcare professional office/clinic visit. On 25Apr2021, the patient underwent Sars-cov-2 RNA, QL, RT PCR (nasal swab) and the result was negative. The clinical outcome of the events got really sick  was resolved on 24Apr2021; while that of  fever, chills, joint pains in hands, knees, hips, back and heels, headache, extreme fatigue and nausea was resolved on an unknown date in Apr2021. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Patient reported throat feeling dry 5 minutes after vaccine administration. He drank some apple juice. He reported that his throat felt tight, and that he was becoming hoarse about 25 minutes after vaccine administration.  He was able to walk to a treatment area, where he was assessed and 0.3 ml Epinephrine by Epi Pen was administered into antero lateral thigh, and EMS was called. Patient reported symptom improvement after 3-5 minutes.  EMS transported patient to the Emergency Department for evaluation.
The night she received vaccine her legs hurt really bad and her husband said she was acting strange. She slept that night and woke disoriented/delirious with a fever of 102 degrees F. She mentioned that as a child she had a history of becoming delirious with a fever. She did not take anything for fever (but did confirm that we went over analgesics were okay to take if needed). Because of the delirium her husband took her to hospital where she was kept overnight for observation. She also developed a large swollen lymph node in her left armpit (no local reaction at injection site). She stated neurologist did say that her reaction was due to SHINGRIX and advised her not to get the second dose. Injection date 5/11/18, admitted to Hospital 5/12/18, discharged 5/13/18 (fever and symptoms were resolved).
Patient pre-treatment BP was 94/54 and pre weight was 56.2. She was initially set for 0.7 removal. Her BP was 68/49, the cuff was resized, rewrapped, and rechecked. Reading 83/53 and she complained of leg cramp her UF was cuff off and 200ml NS given.  Patient then went unresponsive 500 ML of NS given and AED was place on the patient as well as 4L of O2.  Patient recovered and refused EMS transport. But requested tx be ended.  Patient is a poor historian.  Patient says she has been feeling bad since receiving booster 02/10/22.  Patient reported she "fell out" in the bathroom this morning at home and had to be picked up off the floor by her grandson. Per her daughter this did not occur but she has been feeling out of sort since she received the booster.  Patient went non responsive again.  She was given a total of 1800ml NS. Pt was A&O x 3. Needles were removed without incident.  EMS arrived and transported patient to hospital were (privacy) were notified. Spoke to (privacy) after incident, Daughter reports upon arrival to hospital CPR was performed patient's internal defrib shocked her repeatedly.  She was A&O requesting food but will be admitted to ICU for observation and a cardiac work up. On 02/14/2022 Physician reports patient is in-patient ICU with V-fib.
The author of the literature article described clinical characteristics of children alleging seizure disorder as an injury due to vaccination. Retrospective record review of vaccine-alleged seizure disorder cases in children aged <2 years filing a claim during 1995-2006. The NVICP retrieved 242 cases alleging seizure as vaccine injury. Of 96 cases retrieved thus far, 71 were filed in 1995-6, 10 in 1997-2002. Half were male. Vaccines implicated (sometimes multiple) included Hib (manufacturer unknown). 2 patients had a seizure within 72 hours of vaccination. A significant number of children with alleged vaccine induced seizure disorders had pre-existing neurological or neurodevelopmental abnormalities. Among those developing chronic epilepsy, many had clinical features suggesting genetically determined epilepsy. The patients outcome was not reported. Upon internal review, the event of vaccine-alleged seizure disorder was considered medically significant. This is one of several reports from the same source. Additional information is not expected.
Monocytes were at 18.4% (high); This case was reported by a consumer via call center representative and described the occurrence of monocytes increased in a 82-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included aml leukemia.   On 2nd August 2021, the patient received the 1st dose of Shingrix (intramuscular). On 4th August 2021, 2 days after receiving Shingrix, the patient experienced monocytes increased. On an unknown date, the outcome of the monocytes increased was not recovered/not resolved.   It was unknown if the reporter considered the monocytes increased to be related to Shingrix.  Additional details were reported as follows This case was patients daughter reported for her mother. Reported that her mother received her first dose of shingrix. Also reported about her mother was in remission for AML Leukemia. The patient blood drawn and test results was her monocytes was at 18.4% (high). The patient experienced monocytes increased the outcome was not recovered. Did not consent to follow-up. The caller does not give permission to contact.
Case received primary Covid series in February 2021, and was hospitalized for Covid in February 2022. Hospitalized at: Hospital.  Case had multiple medical issues, and Covid added to his overall disease burden.  He was unable to tolerate treatment for Covid,  survived his isolation period and was hospitalized for 39 days, at which point he died.  He had multiple contributing factors listed on his death certificate, but Covid was not one of them.
Client reported anxiety and nausea about one minute after receiving the COVID vaccination Pfizer. Client moved from a regular chair into the in anti-gravity chair. The client reported feeling anxiety and nausea. The client denied any other s/s of anaphylaxis.  The client reports a history of anxiety with is controlled with an oral medication he takes daily for "stress". The client was unsure of the name of the medication name. Vitals obtained at 7:04PM were as follows: automatic BP 135/96, HR 88, O2 99%. The client stated he was "feeling better." The client denied any history of anxiety with injections. The client his current status was a new feeling for him. The client began drinking a juice. Repeat vitals obtained at 7:10PM were as follows: automatic BP 129/88, HR 96, O2 98%. The client denied any persistent nausea at 7:13PM. The client reported "numbness" around the vaccination site. No redness was observed around the vaccination site.  Palpated around the vaccination site and client reported in tact sensation to physical touch. Repeat vitals obtained at 7:10 PM were as follows: Client ambulated to EMT observation area unassisted with a steady gait. At 7:23 PM asked the client if he was feeling okay, and the client replied "yes." At 7:36PM the client stated that he "still feels good." Repeat vitals obtained at 7:36PM were as follows: automatic BP 132/86, HR 88, O2 98%. The client left the vaccination site at 7:36PM. The client ambulated unassisted with a steady gait.
Pt was given 3 pfizer booster 2 months early. Denies any adverse side effects. States he only had a sore arm
Information has been received from a registered nurse concerning an adult female who in July 2007, was vaccinated with a dose of Zostavax (Oka/Merck).  In July 2007, one week after vaccination the patient developed a severe case of poison ivy.  Medical attention was sought and patient was placed on prednisone 60mg by mouth daily.  No other information was provided.  There was no product quality complaint involved.  Additional information has been requested.
allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (allergic reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ALLERGY TO VACCINE (allergic reaction). At the time of the report, ALLERGY TO VACCINE (allergic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication were not reported  Concomitant medication were not reported
Complaint of dizziness and fatigue in post vaccination area at 1:18 pm. Vital signs: BP: 100/70; HR: 100; RR: 20; 02 sats 99%.  Client laid down across mom's lap.  At 1:45 dizziness subsided Repeat VS BP: 90/60; HR: 100; RR: 20; pulse ox 100%.  Was able to drink some water.  Discharged home with parents.
pt recv vax & devel a rash;the pt was seen by dermatologist on 8SEP98 & erythema mult was dx;the reporting nurse did not have any other info;
Information has been received from a licensed practical nurse concerning a 49 year old male with aspirin allergy and bronchitis at the time of vaccination who on 24-APR-2007 was vaccinated with the first dose of Pneumovax 23 (lot #655152/0889F), IM in the left deltoid. Concomitant therapy included Allegra and Flonase. On 26-APR-2007, the patient experienced red blotchy areas, slight warm and sore to touch. Treatment with cool compresses was recommend. Subsequently on an unspecified date, the patient recovered from red blotchy areas, slight warm and sore to touch. Additional information has been requested.
SORENESS  AT SITE, NAUSEA, 104 DEGREE FEVER, WEAKNESS
body achiness, mainly legs, beginning a couple weeks after the shot. I also experienced this reaction after other covid shots. some days are better than others
This spontaneous report as received from a consumer via Clinic refers to a currently 2 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 10-AUG-2017, the patient was vaccinated with improperly stored dose of M-M-R II, recombinant human albumin (rHA) 1 dose unit (Lot # M020073, Expiry date was not reported) for prophylaxis (product storage error). There were no previous temperature excursions recorded. It was unknown if data logger was involved. No adverse effects were reported. There was no product quality complaint involved. This is one of the several reports received from the same reporter.; Sender's Comments: US-009507513-1801USA000166:
Information has been received from a nurse practitioner concerning a 16 year old female patient with "no seizure history" who on an unknown date was vaccinated with a first dose of GARDASIL at her pediatrician's office. Subsequently, the patient experienced seizures. She was taken to the emergency room. On an unknown date, the patient recovered. No product quality complaint was involved. Upon internal review seizures was considered to be an other important medical event. Additional information has been requested.
This spontaneous case was reported by a patient family member or friend and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. In April 2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms) had resolved. No concomitant medications was reported.  It was reported that the flu like symptoms only lasted a day and were not serious.  No treatment medications was reported.   Reporter did not allow further contact
Patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021; Patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021 at 9:54 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 11-Jan-2021 at 9:54 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 70.31 years.  Concomitant medication was not provided.  On 11-Jan-2021, 09 vials were moved to clinic.   On 08-Jan-2021, the vaccines were moved to fridge.  Proposed beyond use date was 07-Feb-2021  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  It was reported that each time a vial was put into a cooler, sometimes there was a period of time of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35 degree Fahrenheit.  On the date of administration, at 02:00 P.M., the temperature recorded was 35 degree Fahrenheit that has been reached by the vial.  Temperature recordings were taken using a brand traceable temperature monitor at every hour.  The vial was not in a frozen state at the time of vaccine administration.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  No treatment medication was provided.   This case was linked to MOD-2022-566976 (Patient Link).
Death; This is a spontaneous report from a non-contactable consumer.   An adult male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot Number: Unknown) as single dose for COVID-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient died on an unspecified date.  It was not reported if an autopsy was performed.  Follow-up attempts are completed. No further information is expected.; Reported Cause(s) of Death: Death
Four days after I received the vaccine (this week Tuesday), I suddenly felt very dizzy and faintish.  I sat down until the dizzy spell passed.  I felt very cold and clammy and nauseous.  My hands were very shaky. I  felt very weak and very tired so I slept the whole day.  Today I woke up and felt the same dizziness, very cold hands and nauseous.  Both times I had diarrhea.  I have never had dizzy spells before so I know this has to be vaccine related.